“The Role of Alemtuzumab in Chronic Lymphocytic Leukaemia Patients With p53 Defects”. Hematology Meeting Reports 1, no. 5 (June 17, 2009). Accessed April 19, 2026. https://journals.pagepress.net/hmr/article/view/638.